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Second hand smoke exposure and the risk of
invasive meningococcal disease in children:
systematic review and meta-analysis
Rachael L Murray*, John Britton and Jo Leonardi-Bee
Abstract
Background: Invasive meningococcal disease remains an important cause of serious morbidity and mortality in
children and young people. There is a growing body of literature to suggest that exposure to passive smoke may
play a role in the development of the disease, therefore we have performed a systematic review to provide a
comprehensive estimate of the magnitude of this effect for smoking by any household member, by individual
family members, and of maternal smoking before and after birth.
Methods: Four databases (Medline, Embase, PsychINFO and CAB Abstracts database) were searched to identify
studies (to June 2012) and reference lists scanned for further studies. Titles, abstracts and full texts were checked for
eligibility independently by two authors. Quality of included studies was assessed using the Newcastle-Ottawa
Scale. Pooled odds ratios (OR) with 95% confidence intervals (CI) were estimated using random effect models, with
heterogeneity quantified using I2.
Results: We identified 18 studies which assessed the effects of SHS on the risk of invasive meningococcal disease
in children. SHS in the home doubled the risk of invasive meningococcal disease (OR 2.18, 95% CI 1.63 to 2.92,
I2 = 72%), with some evidence of an exposure-response gradient. The strongest effect was seen in children under
5 years (OR 2.48, 95% CI 1.51 to 4.09, I2 = 47%). Maternal smoking significantly increased the risk of invasive
meningococcal disease by 3 times during pregnancy (OR 2.93, 95% CI 1.52-5.66) and by 2 times after birth
(OR 2.26, 95% CI 1.54-3.31).
Conclusions: SHS exposure, and particularly passive foetal exposure to maternal smoking during pregnancy,
significantly increases the risk of childhood invasive meningococcal disease. It is likely that an extra 630 cases of
invasive meningococcal disease annually in children under 16 are directly attributable to SHS exposure in UK
homes.
Keywords: Second hand smoke, Environmental tobacco smoke, Invasive meningococcal disease, Systematic review,
Meta-analysis
Background
Invasive meningococcal disease is a catastrophic illness
that can have devastating effects. It is the most common
cause of bacterial meningitis in the UK and Ireland, an
important cause of serious morbidity and mortality in
children and young adults [1] with nearly half of all
cases of laboratory confirmed meningitis in England and
Wales being aged under 14 years [2]. With prompt me-
dical intervention the majority of cases make a full re-
covery, but around 16% are left with at least one major
adverse outcome, such as severe intellectual disability,
epilepsy, spasticity or deafness, whilst nearly 5% of cases
are fatal [3]. At 7 and 12 years after infection, meningitis
survivors demonstrate significantly lower IQ scores and
higher incidences of neurological or behavioural disor-
ders, and particularly those who developed meningitis
during infancy and experienced neurological complica-
tions at the time of the illness [4,5].
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A growing body of literature suggests that exposure to
second hand smoke (SHS) may play a role in the deve-
lopment of meningococcal disease. A recent meta-
analysis limited to 16 large studies estimated this
increase in risk at a relative odds of 2.30 (95% CI 1.74 to
3.06) among children with one or more parent who
smoked [6]. Another recent systematic review found ex-
posure to SHS was associated with a two-fold increased
risk of invasive meningococcal disease in those aged be-
tween 1 month and 19 years old [7], but this study did not
explore the effects of smoking by different family mem-
bers, or the effects of prenatal smoke exposure.
We have therefore carried out a full systematic review
and meta-analysis of all available epidemiological evi-
dence to provide a comprehensive estimate of the effect
of SHS by different family members, and of pre- and
post-natal maternal smoking, on the risk of invasive
meningococcal disease in different stages of childhood.
Methods
Systematic review methods
We identified all comparative epidemiological studies
(case–control, cross-sectional, cohort designs) assessing
the association between SHS exposure and the risk of in-
vasive meningococcal disease in children (aged < 18
years) through a comprehensive search of three elec-
tronic databases (Medline, Embase, and PsychINFO,
searched to June 2012), by scanning reference lists of the
included studies, and using the CAB Abstracts database
(June 2012) to identify relevant conference abstracts.
Case reports, case series and grey data were not
included. The following search terms were used to iden-
tify studies (where ‘mp’ indicates the text was searched
for in the abstract, titles, original titles, broad terms, and
heading words; ‘/’ indicates MeSH terms, ‘exp’ indicates
explosion of MeSH terms): tobacco.mp; cigarette smoke.
mp; smoker.mp; smoking.mp; cigar.mp; exp tobacco/;
exp tobacco dependence/; exp tobacco smoke/; exp
cigarette smoke/; exp cigarette smoking/; exp smoking/;
exp smoke/; exp "smoking and smoking related pheno-
mena"/; exp adolescent smoking/; exp parental smoking/;
exp passive smoking/; exp smoking habit/; exp smoking
cessation/; exp Crowding/; exp tobacco smoke pollution/;
second hand smoke.mp; meningitis.mp; septicaemia.mp;
meninges.mp; bacterial meningitis.mp; viral meningitis.
mp; fungal meningitis.mp; cryptococcal meningitis.mp;
exp meningioma/; exp meningism/; exp meningitis/; exp
central nervous system infection/; exp meninx disorder/;
exp nervous system inflammation/; exp arachnoiditis/; exp
aseptic meningitis/; exp bacterial meningitis/; exp epi-
demic meningitis/; exp fungal meningitis/; exp group b
streptococcal meningitis/; exp haemophilus meningitis/;
exp lymphocytic choriomeningitis/; exp meningoence-
phalitis/; exp pneumococcal meningitis/; exp primary
amebic meningoencephalitis/; exp subdural empyema/;
exp tuberculous meningitis/; exp virus meningitis/; exp
vogt koyanagi syndrome/; exp septicemia/; exp sepsis/;
exp candida meningitis/; exp cryptococcal meningitis/;
exp meningitis, bacterial/; exp meningitis, meningococ-
cal/; exp meningococcal infections/; exp meningitis,
pneumococcal/; exp pneumococcal infections/; exp
Streptococcus pneumoniae/; exp meningitis, haemophi-
lus/; exp haemophilus infections/; meningitis, viral/;
meningitis, aseptic/; virus diseases/; neisseria/; neisseria
meningitidis/; neisseria meningitidis, serogroup a/; neis-
seria meningitidis, serogroup b/; neisseria meningitidis,
serogroup c/; neisseria meningitidis, serogroup w-135/;
neisseria meningitidis, serogroup y/. We imposed no
language restrictions.
Exposure measures
We included all sources of SHS exposure (parental,
household, carer, other family members) measured by ei-
ther self-report (typically by questionnaire) or bioche-
mical markers of exposure such as cotinine in saliva.
Exposures were classified as either in-utero, postnatal,
infant, or childhood exposure. Studies of the effects of
active smoking were excluded.
Outcome measures
We included all studies with invasive meningococcal dis-
ease diagnosed clinically, and/or by laboratory confirm-
ation through identification of pathogens in blood or
CSF, as the outcome. We excluded studies of meningo-
coccal carriage, and studies in which invasive meningo-
coccal disease outcomes could not be clearly extracted
from a broader group of diagnoses.
Study selection
Titles and abstracts identified from the searches were
checked for eligibility independently by two authors
(either RLM and MM, or JLB and MM). Studies deemed
not to be relevant were excluded at each stage. The full
text of potentially eligible papers was sought and also
checked for eligibility independently by two authors
(either RLM and MM, or JLB and MM). Disagreements
were resolved through discussion with a third author.
Data from the included studies relating to a study design,
participants, outcome measures and results were extracted
using a piloted data extraction form independently by two
authors (either RLM and MM, or JLB and MM). Any
paper not published in English was translated at the rele-
vant stage of screening, with data extracted as per English
language papers.
Assessment of methodological quality
Studies deemed eligible for inclusion in the systematic
review were scored for methodological quality using the
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Newcastle-Ottawa Assessment Scale [8]. The scale con-
sists of three categories relating to selection, comparabi-
lity and ascertainment of exposure (for case–control and
cross-sectional studies) or ascertainment of outcome
(for cohort studies), with a maximum score of 9 being
awarded for the highest quality studies. This process was
performed independently by two authors (either RM and
MM, or JLB and MM), with disagreements resolved
through discussion with a third author. A score of six or
more was taken to distinguish higher from lower quality
studies.
Statistical analysis
Estimates of effect were extracted from the papers and
analysed to estimate measures of effect either using
unadjusted (crude) odds ratios (OR), or where possible,
using adjusted ORs; with their associated 95% confi-
dence intervals (CI). Meta-analysis was used to esti-
mate the effects of SHS exposure and the risk of
invasive meningococcal disease using random effects
models, due to anticipated high levels of heterogeneity
between the included studies. Separate analyses were
carried out for each exposure measure (in-utero and
childhood exposure) where possible. For studies which
solely reported categories of cigarette consumption,
we used the highest category of cigarette consumption
for the analyses. Heterogeneity was quantified using
recognised methods (I2) [9], and where high levels of
heterogeneity (I2 > 50%) were detected between the
studies we performed subgroup and sensitivity ana-
lyses to explore the effects age of the participants (<5
versus ≤18 years of age), ascertainment of disease (la-
boratory confirmed cases only versus case definition
including non confirmed cases), and methodological
quality of the studies (score <6 versus ≤6). Where ex-
treme levels of heterogeneity were detected between
the studies (I2 > 80%), we did not perform an overall
meta-analysis.
Small study bias (publication bias) was assessed visually
using a funnel plot and Eggers test for Asymmetry [10].
The effect of publication bias was assessed using the
‘Tim and Fill’ procedure [11], by which the pooled OR
and 95% CI are re-calculated after imputation of the
results of hypothetically missing studies which would be
needed to minimise the effect of publication bias. Statis-
tical analysis was performed using Review Manager 5 (Re-
view Manager (RevMan) [Computer program]. Version
5.0. Copenhagen: The Nordic Cochrane Centre, The
Cochrane Collaboration, 2008), and STATA version 11
MP (StataCorp LP, 4905 Lakeway Drive, College Station,
TX, USA). P values <0.05 were taken as statistically signifi-
cant. We adhered to the MOOSE guidelines throughout
the review process [12].
Population attributable fraction estimation
We estimated the proportion of children in England
(aged four to 15 years) who live in a household in which
at least one person smokes using data from the Health
Survey for England [6], and the formula p(OR-1)/
[p(OR-1) + 1], in which p is the proportion of the cohort
exposed to SHS (defined as the proportion of children
who did not live in a smoke-free home, where a smoke-
free home was defined as living in a home without regular
smoking indoors), and OR the odds ratio for invasive
meningococcal disease in children where a member of the
household smokes, to estimate the proportion of children
with invasive meningococcal disease attributable to house-
hold smoking exposure. We then used national invasive
meningococcal disease incidence data for the UK [6] to es-
timate the number of disease episodes generated as a re-
sult of household SHS exposure.
Results
Overview of included studies
Of a total of 4534 papers identified from the searches,
193 titles were deemed to be potentially eligible for in-
clusion. After checking the abstracts of these 193 studies
we identified 48 potentially eligible papers. The full texts
of these papers were reviewed, and 18 deemed eligible
for inclusion in the systematic review (Figure 1, Table 1).
The 30 full text papers that were excluded comprised 10
that investigated meningococcal carriage rather than in-
vasive meningococcal disease [13-22], two in which inva-
sive meningococcal disease could not be distinguished
from a wider group of disease outcomes [23,24], four
that looked only at Haemophilus influenza type B (HiB)
and Pneumococcal infections [25-28], one that studied
bacterial sepsis [29], three that focussed only on adult
populations [30-32], four that were reviews [33-36], five
with no reference group [37-41], and one duplicate re-
port of a study included in the review [42] (Figure 2).
The majority of the included studies used case–control
designs, and two were cohort studies [43,44]. Cases in
the included studies were defined in different ways, with
eight studies using only laboratory confirmed diagnosis
[43-50] , with one taking cases identified by death certifi-
cates [44]. In the remaining 10 studies, case definition
allowed for both laboratory confirmed diagnoses and
non-confirmed (probable) diagnoses, through clinical
diagnosis of symptoms [51-60].
Methodological quality of studies and Publication Bias
The methodological quality scores for the included stu-
dies ranged from 3 to 9, with a median 6; 11 studies
(61%) were deemed to be of a high quality (≥6). The me-
dian scores for the three categories were 3 for selection, 2
for comparability and 1.5 for ascertainment of exposure/
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outcome. Lower quality scores tended to arise from me-
thods of selection and ascertainment of exposure/outcome.
Passive smoke exposure in the household
All of the included studies assessed exposure to SHS
using questionnaires. A pooled analysis found exposure
to SHS by any smoker in the household more than
doubled the risk of invasive meningococcal disease (OR
2.18, 95% CI 1.63 to 2.92, I2 = 72%, 17 studies; Figure 2).
Seventeen of the included papers were used in the meta-
analysis, the exception being one that did not provide
effect estimates; however, this study found a significant
increase in the risk of meningitis in children <12 years
who were exposed to moderate or heavy amounts of
passive smoke (P < 0.001) [53].
Subgroup analysis based on methodological quality
found higher pooled estimates for lower quality studies
(OR 2.53, 95% CI 1.25 to 5.13; I2 = 68%) than higher
quality (OR 2.09, 95% CI 1.50 to 2.90; I2 = 75%) studies
(Figure 2). A subgroup analysis based on case definition
found the estimates in those studies that used laboratory
confirmed cases only were more homogeneous (OR
2.71, 95% CI 1.71 to 4.29, I2 = 56%) compared to studies
which included non-confirmed (probable) cases (OR
1.86, 95% CI 1.27 to 2.73, I2 = 77%) (Figure 3). Stronger
magnitudes of effect were seen for the association be-
tween SHS exposure in the household and the risk of in-
vasive meningococcal disease in children under 5 years
(OR 2.48, 95% CI 1.51 to 4.09, I2 = 47%) compared to
the association seen in children <18 years (OR 2.02, 95%
CI 1.44 to 2.85, I2 = 75%) (Figure 4).
Maternal or paternal smoking
One paper that assessed smoking in the mother during
pregnancy found more than a doubling of the risk of in-
vasive meningococcal disease (OR 2.93, 95% CI 1.52 to
5.66; Figure 5). Exposure to maternal smoking after birth
was also found to double the risk of invasive meningo-
coccal disease (OR 2.26, 95% CI 1.54 to 3.31, I2 = 66%, 7
studies; Figure 5). Extreme levels of heterogeneity were
Total papers identified n=4534
Papers retained after reviewing 
titles n= 193 
Papers excluded after 
reviewing titles n=4341 
Papers retained after reviewing 
abstracts n=48 
Papers excluded after 
reviewing abstracts n=145 
Papers retained after reviewing 
full paper n=18 
Paper excluded after reviewing 
full paper n=30: 
17 incorrect outcome 
3 incorrect population 
4 reviews 
5 no reference group 
1 duplicate paper 
 Final number of papers 
included in meta-analysis n=17 
Paper excluded from meta-
analysis n=1 
Figure 1 Flow diagram of included and excluded studies.
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detected between the studies which assessed the effect
of exposure to paternal smoking on the risk of invasive
meningococcal disease (I2 = 81%; Figure 5); therefore,
the results for these four studies are presented narra-
tively. Two of the studies demonstrated significantly
increased risks of invasive meningococcal disease asso-
ciated with exposure to parental smoking (OR 3.21, 95%
CI 1.49 to 6.93 [48]; OR 3.53, 95% CI 1.64 to 7.58 [55];
however, the remaining studies either showed a non-
significant increase (OR 1.33, 95% CI 0.90 to 1.97 [57] or a
non-significant decrease (OR 0.78, 95% CI 0.48 to 1.27 [54].
One study that assessed exposure to both parents smoking
found an eight-fold increase in the risk of invasive menin-
gococcal disease (OR 8.23, 95% CI 2.31 to 29.31; Figure 5).
Table 1 Characteristics of included studies
Author & Year Setting Design and study
population
Exposure Ascertainment
of disease
NOS
Baker 2000[51] New-Zealand Case–control: 202 cases,
313 controls
One or more smokers in household Laboratory confirmed
and probable
6
Coen 2006[52] England Case–control: 144 cases,
144 controls
Exposure to smokers, exposure to smoke. Laboratory confirmed
and probable
5
Conde 2003
[45]
Portugal Case–control: 47 cases,
51 controls
Maternal smoking Laboratory confirmed 6
Fischer 1997
[46]
State of Washington,
USA
Case–control: 129 cases,
274 controls
Maternal smoking, passive tobacco
smoke
Laboratory confirmed 7
Grein 2001[47] Republic of Ireland Case–control: 87 cases,
267 controls
Household smoking Laboratory confirmed 8
Haneberg 1983
[53]
Norway Case–control: 115 cases,
61 patient controls,
293 population controls
Heavy/moderate smoke exposure Laboratory confirmed
and probable
4
Hodgson 2001
[54]
Kassena-Nankana
district, Ghana.
Case–control: 505 cases,
505 controls.
Paternal smoking Laboratory confirmed
and probable
8
Kriz 2000[48] Czech republic Case control: 68 cases,
135 controls
Maternal smoking, Paternal smoking,
Maternal smoking only, Paternal smoking
only, Both parents smoking, Smoking at
home per 20 cigarettes a day
Laboratory confirmed 7
Krizova 1999
[55]
Czech republic Case control: 107 cases,
211 controls
Maternal smoking, Paternal smoking,
another member of family
Laboratory confirmed
and probable
5
McCall 2004
[49]
Area covered by the
SPHUN, Queensland,
Australia
Case control: 62 cases,
79 controls
Passive tobacco smoke exposure,
carer smoking.
Laboratory confirmed 4
Moodley 1999
[56]
Cape town metropolitan
region, South Africa.
Case control: 70 cases,
210 controls
More than 2 Smokers per household,
Main caregiver smokes
Laboratory confirmed
and probable
3
Pereiro 2004
[57]
Valencia, Spain Case control: 181 cases,
243 controls.
Under 15s: No. of smokers, Maternal smoking,
Paternal smoking, Other smoking, No of
cigarettes smoked by other at home <10,
10 – 20, 20>. Under 5s: No of cigarettes
smoked; 10 to 29,30 to 59.
Laboratory confirmed
and probable
5
Robinson 2001
[58]
Victoria, Australia Case control: 47 cases,
94 controls
Smoker amongst intimate contact. Laboratory confirmed
and probable
7
Sorensen 2004
[59]
Denmark Case control: 462 cases,
9240 controls.
Maternal smoking Laboratory confirmed
and probable
7
Stanwell-Smith
1994[50]
West England Case control: 74 cases,
232 controls
Any household smoker, Smoking at home,
Smoking on visits, Cigarettes smoked per
day in home;1-9, 10-19, 20-29, 30 or more.
Number of smokers in the household;
None, One, Two, Three or more.
Laboratory confirmed 5
Stuart 1988[60] England Case control: 105 cases,
105 controls.
Other smokers in the household Laboratory confirmed
and probable
6
Tully 2006[43] England Cohort: 144 cases,
144 controls
Multiple close contacts who smoke Laboratory confirmed 9
Yusuf 1999[44] Atlanta, USA Cohort: 283291 people,
including 55 cases.
Mother smoked during pregnancy Laboratory confirmed 8
NOS Newcastle-Ottawa Scale for assessing methodological quality of studies.
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Figure 2 Smoking by any smoker in the household and the risk of invasive meningococcal disease: subgroup analysis by
methodological quality. Squares indicate the odds ratio and bars represent 95% confidence intervals (CI). Odds ratios more than one indicate
smoke exposure in the household increases the risk of invasive meningococcal disease in children.
Figure 3 Smoking by any smoker in the household and the risk of invasive meningococcal disease: subgroup analysis by case
definition. Squares indicate the odds ratio and bars represent 95% confidence intervals (CI). Odds ratios more than one indicate smoke exposure
in the household increases the risk of invasive meningococcal disease in children.
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Publication bias
There was some evidence of small study bias (publica-
tion bias) identified in the funnel plot (Figure 6) and
Egger’s test (p = 0.033) for the association between ex-
posure to household smoke and the risk of invasive
meningococcal disease (17 studies included). The ‘Trim
and Fill’ procedure identified six studies would be
needed to minimise the effect of publication bias. The
ORs and 95% CI for the six hypothetical studies were
imputed into the meta-analysis, which resulted in a bias-
corrected OR of 1.59 (95% CI 1.17 to 2.15, p = 0.003; 23
studies).
Population attributable fraction
Health survey for England data indicate that in 2007,
around 22% of children aged from four to 15 years lived
in a household in which someone smokes (defined as
the proportion of children who did not live in a smoke-
free home, where a smoke-free home was defined as li-
ving in a home without regular smoking indoors) [6].
Using the pooled odds ratio for household smoking from
our meta-analysis (2.18) as the estimated relative risk of
developing invasive meningococcal disease, the propor-
tion of children developing invasive meningococcal dis-
ease likely to be attributable to exposure to smoking in
the home is estimated at 20.6%. In 2008 there were ap-
proximately 3,070 events of invasive meningococcal di-
sease in children under the age of 16 years in the UK
[6]. A 20.6% attributable fraction translates into approxi-
mately 630 new cases of invasive meningococcal disease
each year arising from exposure to smoking in the home
in the UK. Allowing for the effects of publication bias
using the bias-corrected odds ratio for household smoking
(1.59) results in a bias-corrected population attributable
fraction of 11.5%, which translates to an additional 350
cases of invasive meningococcal disease per year arising
from exposure to smoking in the home.
Discussion
This systematic review and meta-analysis of all available
epidemiological evidence of the effect of SHS exposure
on the clinical manifestation of invasive meningococcal
disease confirms that exposure to SHS in the household
more than doubles the risk of invasive meningococcal
disease, that this finding is consistent across both higher
and lower quality studies, and is stronger for laboratory
confirmed than clinically diagnosed outcomes. The effect
appears to be particularly strong in households in which
both parents smoke, and with prenatal or postnatal ma-
ternal smoking. The effects were strongest in children
aged under five years. We estimate that around 630 UK
cases of invasive meningococcal disease in children
under 16 years are currently attributable to maternal or
paternal smoking. With an estimated 5% mortality this
translates into about 30 deaths per year.
Figure 4 Smoking by any smoker in the household and the risk of invasive meningococcal disease: subgroup analysis by age of study
population. Squares indicate the odds ratio and bars represent 95% confidence intervals (CI). Odds ratios more than one indicate smoke
exposure in the household increases the risk of invasive meningococcal disease in children.
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Strengths and limitations
The data included in this review were included after
comprehensive literature searches and hand searching of
previous reviews and reference lists of published articles.
Our findings are therefore likely to be representative of
the true effect of SHS exposure on the development of
invasive meningococcal disease. This review built on a
recent meta-analysis that we performed as part of a
broader review of the effects of passive smoking in chil-
dren, for a Royal College of Physicians report [6]. How-
ever, the meta-analysis was limited as it included
clinically heterogeneous studies of meningococcal and
Figure 6 Smoking by any smoker in the household and the risk of invasive meningococcal disease: funnel plot.
Figure 5 Maternal and paternal smoking and the risk of invasive meningococcal disease. Squares indicate the odds ratio and bars
represent 95% confidence intervals (CI). Odds ratios more than one indicate maternal and paternal smoke exposure increases the risk of invasive
meningococcal disease in children.
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other bacterial meningitis, and also included studies
assessing the effects on meningococcal carriage. Further-
more, the review failed to investigate reasons for hetero-
geneity between the studies using subgroup analysis. In
the current review, we have presented a more compre-
hensive systematic review which advances the findings
previously published by addressing the limitations above.
Further to the review published in 2010 [7], we were able
to include an additional three eligible studies [44,45,55]
which were previously not identified or included. Two of
the included studies used very similar populations based
on a surveillance program with data collection over the
same period of time [48,55]; however, both were included
in the analyses as they contributed to different subgroup
categories, therefore there was insufficient evidence to
ascertain whether they were mutually exclusive. We
imposed no language restrictions on the search, which
allowed us to include all articles of interest. The current
study was limited by an inability to adjust for a full range
of confounders in the analyses due to large variations in
the published papers. Higher quality studies tended to ad-
just for age, overcrowding and socio-economic status but
this was not always the case, particularly in lower quality
studies. Factors such as hygiene and exposure to other
sources of smoke, such as from cooking (as found by
Hodgson et al. 2001 [54]), were not commonly adjusted
for and may have affected the results gained. There was
also some evidence of publication bias towards smaller
studies showing either a protective effect or no effect;
however, the bias-corrected pooled estimate still demon-
strated a strong and significant increase in the odds of in-
vasive meningococcal disease associated with exposure to
SHS. Varied definitions of SHS were used within the
included studies and ranged from only including smoking
from particular household members, for example based
solely on exposure to smoking from the mother; through
to assessing smoke exposure from more than one source,
for example based on exposure to smoking from any
household family members, visitors to the household, and
exposure at day care settings. It would have been interest-
ing to separate ‘exposure to smokers' from 'exposure to
smoking' to investigate any differential effects, however,
meaningful subgroup comparisons were not possible due
to the numerous ways that the included studies defined
passive smoke exposure, as indicated in Table 1. A further
limitation of the review relates to the inability to assess
whether there was evidence of effect modification, for ex-
ample by crowded households, due to the studies not pre-
senting their data in suitable formats to enable this.
This review has demonstrated that the increase in risk
of invasive meningococcal disease is primarily due to
smoking by the mother, either during pregnancy or post-
natally. It is a difficult to disentangle the independent
effects of smoking during pregnancy from that in the
postnatal period due to the high concordance of smo-
king by the mother in the two periods; however smoking
in pregnancy is known to increase the risk of other va-
rious childhood infections, for example lower respiratory
infection [61]. Only one study included in this review
assessed the effect of smoking in pregnancy on the risk
of invasive meningococcal disease [44], which demon-
strated a substantial increase in risk; however, further
well-conducted studies are needed to describe this asso-
ciation conclusively, and to assess the effect of SHS
smoke exposure during different stages of pregnancy.
Sir Austin Bradford Hill’s postulates to review whether
there is sufficient evidence in support of a causative role
of SHS exposure on invasive meningococcal disease [62].
The meta-analysis conducted in this review demonstrated
a consistent, marked strength in association between SHS
exposure and invasive meningococcal disease; however,
the specificity criterion is unlikely to be met, since invasive
meningococcal disease is known to be caused by factors
other than exposure to SHS. In terms of temporal se-
quence, we only identified two cohort studies of passive
smoking and invasive meningococcal disease [43,44]; both
of the studies were judged to be of high quality and both
demonstrated clear marked increases. There was some
evidence of a biological gradient where stronger magni-
tudes of effect were seen in those exposed to higher num-
bers of cigarettes smoked in the home per day [50,57],
specifically where no effect was seen in those exposed to
less than 10 cigarettes per day, but a doubling in risk of in-
vasive meningococcal disease was seen in those exposed
to moderate amounts of cigarettes per day, and a 3 to 4
fold increase in those heavily exposed to cigarette smoke
per day. In terms of biological plausibility and coherence
with what is already known, the possible mechanisms for
how SHS exposure may induce invasive meningococcal
disease may be related to the effects of tobacco acting sys-
temically reducing the defences of the nasopharyngeal
mucosa against potential pathogens [46,50]. However,
current knowledge also suggests higher carriage rates in
smoking parents [63], thus exposure to smoke in child-
hood may increase the exposure to the pathogen. Very
little research has been performed to support the experi-
mental evidence criterion by, for example, assessing the
effects of smoking cessation in homes of children
exposed to parental smoke on the reduced risk of inva-
sive meningococcal disease, however, in terms of analo-
gous evidence; there is growing evidence to suggest the
causal effect of SHS exposure on other childhood infec-
tions. Therefore there seems to be some evidence to
support SHS as a causative factor of invasive meningo-
coccal disease.
The results of this study are limited to presentations
of confirmed or clinically probable invasive meningococ-
cal disease as these are the outcomes directly relevant to
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estimating the effect of SHS on disease risk. We did not
explore the effects of SHS on carriage rate, though such
studies would be of value to determine whether smoking
increases the risk of disease through increased carriage,
or increased progression to disease among those carrying
the relevant pathogens.
Conclusion
Our results demonstrate a further means by which pas-
sive smoking presents a significant risk to the health and
wellbeing of young children. Interventions to prevent
SHS exposure to cigarette smoke from parents and other
household members therefore remain an urgent priority.
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